In addition, p-synephrine was predicted to exert its anti-obesity effect via calcium and cAMP signaling pathways by targeting adrenergic receptors, ADRB1, ADRB2, and ADRB3. This evidence concerns the gene ADRB2 and obesity due to melanocortin 4 receptor deficiency.